VistaGen Therapeutics, Inc.·4

Aug 22, 5:12 PM ET

GIN JERRY B 4

4 · VistaGen Therapeutics, Inc. · Filed Aug 22, 2022

Insider Transaction Report

Form 4
Period: 2022-08-18
GIN JERRY B
Director
Transactions
  • Purchase

    Common Stock

    2022-08-18$0.18/sh+100,000$17,870100,000 total(indirect: By Spouse)
  • Purchase

    Common Stock

    2022-08-18$0.18/sh+100,000$17,870100,000 total
Holdings
  • Common Stock

    (indirect: By LLC)
    100,000
  • Common Stock

    (indirect: By LLC)
    100,000
Footnotes (3)
  • [F1]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.1772 to $0.1805, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote (1) to this Form 4.
  • [F2]Jermax, LLC is wholly owned and controlled by the Reporting Person.
  • [F3]Pegmax, LLC is wholly owned and controlled by the Reporting Person's spouse.

Documents

1 file
  • 4
    form4-08222022_020840.xmlPrimary